Skip to main content
. 2022 Aug 16;13:979939. doi: 10.3389/fphar.2022.979939

FIGURE. 3.

FIGURE. 3

Z1456467176 inhibits the P2X7R-NLRP3-IL-1β pathway in vitro. (A) WB of NLRP3, caspase-1 (p20), and IL-1β in lysates from LPS-primed PBMCs of gout patients treated with Z1456467176 (10, 50 μM) for 30 min and stimulated with BzATP (100 μM). (B–D) ELISA of IL-1β, TNF-α, and IL-6 in culture supernatants from LPS-primed PBMCs of gout patients treated with Z1456467176 for 30 min and stimulated with BzATP. Data are presented as the means ± S.E.M.s. Statistics were analyzed using Dunnett’s t test. n = 3. ***p < 0.001.